PortfoliosLab logoPortfoliosLab logo

Documentation

Upgrade your plan
MAERSK-B.CO vs. NVZMY
Performance
Return for Risk
Dividends
Drawdowns
Volatility
Financials

MAERSK-B.CO vs. NVZMY

Last updated Apr 3, 2026

Compare and contrast key facts about A.P. Møller - Mærsk A/S (MAERSK-B.CO) and Novozymes AS (NVZMY).

Performance

MAERSK-B.CO vs. NVZMY - Performance Comparison

The chart below illustrates the hypothetical performance of a DKK 10,000 investment in A.P. Møller - Mærsk A/S (MAERSK-B.CO) and Novozymes AS (NVZMY). The values are adjusted to include any dividend payments, if applicable.

Loading graphics...

MAERSK-B.CO vs. NVZMY - Yearly Performance Comparison

2026 (YTD)202520242023202220212020201920182017
MAERSK-B.CO
A.P. Møller - Mærsk A/S		12.55%35.07%8.09%9.48%-24.99%76.87%46.00%37.44%-23.04%-2.29%
NVZMY
Novozymes AS		-2.75%0.90%10.88%9.33%-34.62%57.70%7.94%12.86%-17.00%48.90%
Different Trading Currencies

MAERSK-B.CO is traded in DKK, while NVZMY is traded in USD. To make them comparable, the NVZMY values have been converted to DKK using the latest available exchange rates.

Returns By Period

In the year-to-date period, MAERSK-B.CO achieves a 12.55% return, which is significantly higher than NVZMY's -2.75% return. Over the past 10 years, MAERSK-B.CO has outperformed NVZMY with an annualized return of 17.49%, while NVZMY has yielded a comparatively lower 4.31% annualized return.

MAERSK-B.CO

1D
-0.31%
1M
-5.09%
YTD
12.55%
6M
30.67%
1Y
38.99%
3Y*
17.03%
5Y*
16.51%
10Y*
17.49%

NVZMY

1D
0.00%
1M
7.18%
YTD
-2.75%
6M
0.98%
1Y
-0.97%
3Y*
5.80%
5Y*
0.78%
10Y*
4.31%
*Multi-year figures are annualized to reflect compound growth (CAGR)

Compare stocks, funds, or ETFs

Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.

A.P. Møller - Mærsk A/S

Novozymes AS

Often compared with MAERSK-B.CO:
MAERSK-B.CO vs. SBMAERSK-B.CO vs. DSV.COMAERSK-B.CO vs. KHNGYMAERSK-B.CO vs. VWDRYMAERSK-B.CO vs. DANSKE.COMAERSK-B.CO vs. UPS
Often compared with NVZMY:
NVZMY vs. DSV.CONVZMY vs. MAERSK-A.CONVZMY vs. ZEAL.CONVZMY vs. NVONVZMY vs. NOVO-B.CONVZMY vs. GMABNVZMY vs. SNY

Return for Risk

MAERSK-B.CO vs. NVZMY — Risk / Return Rank

Compare risk-adjusted metric ranks to identify better-performing investments over the past 12 months.
MAERSK-B.CO
MAERSK-B.CO Risk / Return Rank: 6868
Overall Rank
MAERSK-B.CO Sharpe Ratio Rank: 7070
Sharpe Ratio Rank
MAERSK-B.CO Sortino Ratio Rank: 6565
Sortino Ratio Rank
MAERSK-B.CO Omega Ratio Rank: 6464
Omega Ratio Rank
MAERSK-B.CO Calmar Ratio Rank: 6868
Calmar Ratio Rank
MAERSK-B.CO Martin Ratio Rank: 7272
Martin Ratio Rank
NVZMY
NVZMY Risk / Return Rank: 4242
Overall Rank
NVZMY Sharpe Ratio Rank: 4646
Sharpe Ratio Rank
NVZMY Sortino Ratio Rank: 3939
Sortino Ratio Rank
NVZMY Omega Ratio Rank: 3939
Omega Ratio Rank
NVZMY Calmar Ratio Rank: 4343
Calmar Ratio Rank
NVZMY Martin Ratio Rank: 4343
Martin Ratio Rank
The rank (0–100) shows how this investment's returns compare to the risk taken. Higher = better. Based on the past 12 months of data, combining Sharpe, Sortino, and other metrics used by quantitative funds and institutional investors.

MAERSK-B.CO vs. NVZMY - Risk-Adjusted Trends Comparison

This table presents a comparison of risk-adjusted performance metrics for A.P. Møller - Mærsk A/S (MAERSK-B.CO) and Novozymes AS (NVZMY). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.

MAERSK-B.CONVZMYDifference

Sharpe ratio

Return per unit of total volatility

0.91

-0.04

+0.95

Sortino ratio

Return per unit of downside risk

1.45

0.14

+1.31

Omega ratio

Gain probability vs. loss probability

1.19

1.02

+0.17

Calmar ratio

Return relative to maximum drawdown

1.42

-0.03

+1.45

Martin ratio

Return relative to average drawdown

4.14

-0.05

+4.19

Data is calculated on a 1-year rolling basis and updated daily. The trend shows the change in the indicator over the past month.

MAERSK-B.CO vs. NVZMY - Sharpe Ratio Comparison

The current MAERSK-B.CO Sharpe Ratio is 0.91, which is higher than the NVZMY Sharpe Ratio of -0.04. The chart below compares the historical Sharpe Ratios of MAERSK-B.CO and NVZMY, offering insights into how both investments have performed under varying market conditions. These values are calculated using daily returns over the previous 12 months.

Loading graphics...

Sharpe Ratios by Period

MAERSK-B.CONVZMYDifference

Sharpe Ratio (1Y)

Calculated over the trailing 1-year period

0.91

-0.04

+0.95

Sharpe Ratio (5Y)

Calculated over the trailing 5-year period

0.41

0.03

+0.38

Sharpe Ratio (10Y)

Calculated over the trailing 10-year period

0.46

0.17

+0.29

Sharpe Ratio (All Time)

Calculated using the full available price history

0.33

-0.05

+0.38

Correlation

The correlation between MAERSK-B.CO and NVZMY is 0.21, which is considered to be low. This implies their price changes are not closely related. A low correlation is generally favorable for portfolio diversification, as it helps to reduce overall risk by spreading it across multiple assets with different performance patterns.

Dividends

MAERSK-B.CO vs. NVZMY - Dividend Comparison

MAERSK-B.CO's dividend yield for the trailing twelve months is around 3.00%, more than NVZMY's 2.73% yield.

TTM20252024202320222021202020192018201720162015
MAERSK-B.CO
A.P. Møller - Mærsk A/S		3.00%7.65%4.33%36.81%16.63%1.46%1.15%1.62%2.18%1.65%3.17%26.18%
NVZMY
Novozymes AS		2.73%1.51%1.03%2.68%1.68%0.69%0.91%1.03%1.10%1.64%0.95%0.60%

Drawdowns

MAERSK-B.CO vs. NVZMY - Drawdown Comparison

The maximum MAERSK-B.CO drawdown since its inception was -69.40%, smaller than the maximum NVZMY drawdown of -83.94%. Use the drawdown chart below to compare losses from any high point for MAERSK-B.CO and NVZMY.

Loading graphics...

Drawdown Indicators

MAERSK-B.CONVZMYDifference

Max Drawdown

Largest peak-to-trough decline

-69.40%

-86.29%

+16.89%

Max Drawdown (1Y)

Largest decline over 1 year

-18.09%

-29.64%

+11.55%

Max Drawdown (5Y)

Largest decline over 5 years

-43.52%

-51.86%

+8.34%

Max Drawdown (10Y)

Largest decline over 10 years

-57.49%

-51.86%

-5.63%

Current Drawdown

Current decline from peak

-11.53%

-59.08%

+47.55%

Average Drawdown

Average peak-to-trough decline

-23.04%

-57.40%

+34.36%

Ulcer Index

Depth and duration of drawdowns from previous peaks

8.67%

15.04%

-6.37%

Volatility

MAERSK-B.CO vs. NVZMY - Volatility Comparison

A.P. Møller - Mærsk A/S (MAERSK-B.CO) has a higher volatility of 11.60% compared to Novozymes AS (NVZMY) at 8.27%. This indicates that MAERSK-B.CO's price experiences larger fluctuations and is considered to be riskier than NVZMY based on this measure. The chart below showcases a comparison of their rolling one-month volatility.

Loading graphics...

Volatility by Period

MAERSK-B.CONVZMYDifference

Volatility (1M)

Calculated over the trailing 1-month period

11.60%

8.27%

+3.33%

Volatility (6M)

Calculated over the trailing 6-month period

25.63%

19.00%

+6.63%

Volatility (1Y)

Calculated over the trailing 1-year period

40.95%

26.35%

+14.60%

Volatility (5Y)

Calculated over the trailing 5-year period, annualized

40.38%

26.23%

+14.15%

Volatility (10Y)

Calculated over the trailing 10-year period, annualized

38.45%

25.96%

+12.49%

Financials

MAERSK-B.CO vs. NVZMY - Financials Comparison

This section allows you to compare key financial metrics between A.P. Møller - Mærsk A/S and Novozymes AS. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.

Quarterly
Annual

Total Revenue: Total amount of money received from sales and other business activities

Please note, different currencies. MAERSK-B.CO values in DKK, NVZMY values in USD